Vandana G. Abramson, MD

Vandana G. Abramson, MD

Vandana G. Abramson, MD, of Vanderbilt-Ingram Cancer Center

Articles by Vandana G. Abramson, MD

Sara Nunnery, MD, MSCI, breast medical oncologist, director, Breast Cancer Research, Tennessee Oncology; Vandana G. Abramson, MD, professor, medicine, co-leader, Breast Cancer Research Program, Breast Cancer Disease Team leader, Vanderbilt Health and the Vanderbilt-Ingram Cancer Center

Oral SERDs Transform Metastatic Breast Cancer Management: With Sara Nunnery, MD, MSCI; and Vandana G. Abramson, MD

BySara Nunnery, MD, MSCI,Vandana G. Abramson, MD

June 16th 2026

Nunnery and Abramson discussed the transformative effects of next-generation oral SERDs in hormone receptor–positive breast cancer management.

Latest Updated Articles

Trending on OncLive

RP1 Plus Nivolumab Preserves Quality-Adjusted Survival in Advanced Melanoma After Anti–PD-1 Therapy

Afami-Cel Outcomes Are Tied to MAGE-A4 Expression, Tumor Burden in Synovial Sarcoma

STX-001 Produces Durable Systemic Responses in PD-1–Resistant Melanoma

VET3-TGI Generates Responses in Checkpoint Inhibitor–Refractory Cutaneous Cancers

Dr Isakoff on Data for Invikafusp Alfa Plus Sacituzumab Govitecan in Advanced HR+ or Triple-Negative Breast Cancer